Perspective Therapeutics
Clinical trials sponsored by Perspective Therapeutics, explained in plain language.
-
Tiny 'Alpha-Particle' bullets target Hard-to-Treat cancers in new trial
Disease control Recruiting nowThis early-stage trial is testing a new type of targeted radiation therapy for people with advanced solid tumors that have stopped responding to standard treatments. The therapy uses a radioactive drug designed to seek out and deliver a powerful, short-range form of radiation dir…
Phase: PHASE1, PHASE2 • Sponsor: Perspective Therapeutics • Aim: Disease control
Last updated Apr 04, 2026 06:20 UTC
-
Targeted 'Alpha' radiation zaps tough melanoma in new trial
Disease control Recruiting nowThis study is testing a new type of targeted radiation drug called [212Pb]VMT01 for people with advanced melanoma that has returned or spread and has not responded to other treatments. The drug is designed to deliver a powerful dose of radiation directly to melanoma cells. Resear…
Phase: PHASE1, PHASE2 • Sponsor: Perspective Therapeutics • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC
-
Breakthrough radiation therapy targets Hard-to-Treat cancers with pinpoint precision
Disease control Recruiting nowThis study is testing a new targeted radiation treatment for adults with advanced neuroendocrine tumors that cannot be surgically removed or have spread. The treatment uses a radioactive substance that seeks out and delivers powerful radiation directly to cancer cells while tryin…
Phase: PHASE1, PHASE2 • Sponsor: Perspective Therapeutics • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC